Nuvectis Pharma Inc
NASDAQ:NVCT
Cash Flow Statement
Cash Flow Statement
Nuvectis Pharma Inc
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
(13)
|
(19)
|
(19)
|
(20)
|
(22)
|
(22)
|
(22)
|
(22)
|
(21)
|
(19)
|
(19)
|
(20)
|
(22)
|
(25)
|
|
| Stock-Based Compensation |
3
|
3
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
|
| Other Non-Cash Items |
1
|
2
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
|
| Change in Working Capital |
1
|
2
|
4
|
2
|
2
|
3
|
2
|
2
|
2
|
1
|
2
|
3
|
4
|
5
|
|
| Cash from Operating Activities |
(11)
N/A
|
(16)
-40%
|
(14)
+13%
|
(15)
-13%
|
(17)
-10%
|
(16)
+7%
|
(16)
-2%
|
(16)
+3%
|
(14)
+7%
|
(14)
+6%
|
(12)
+10%
|
(12)
+4%
|
(12)
-3%
|
(14)
-17%
|
|
| Investing Cash Flow | |||||||||||||||
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
20
|
36
|
32
|
17
|
30
|
16
|
16
|
21
|
9
|
9
|
12
|
24
|
23
|
19
|
|
| Other |
(3)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(2)
|
(2)
|
13
|
|
| Cash from Financing Activities |
17
N/A
|
32
+83%
|
28
-13%
|
14
-50%
|
28
+98%
|
14
-50%
|
15
+7%
|
20
+29%
|
8
-59%
|
9
+10%
|
12
+33%
|
23
+96%
|
21
-6%
|
33
+55%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
6
N/A
|
16
+158%
|
14
-13%
|
(1)
N/A
|
11
N/A
|
(2)
N/A
|
(1)
+45%
|
4
N/A
|
(6)
N/A
|
(5)
+25%
|
(1)
+88%
|
11
N/A
|
9
-16%
|
18
+97%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(11)
N/A
|
(16)
-40%
|
(14)
+13%
|
(15)
-13%
|
(17)
-10%
|
(16)
+7%
|
(16)
-2%
|
(16)
+3%
|
(14)
+7%
|
(14)
+6%
|
(12)
+10%
|
(12)
+4%
|
(12)
-3%
|
(14)
-17%
|
|